why choose us

First received: January 11, 2023

Clinical Trial: A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Asthma

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

Brief Summary: A study to evaluate the efficacy and safety of benralizumab administered subcutaneously in patients ? 6 to < 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations and uncontrolled asthma receiving high-dose inhaled corticosteroid (ICS) plus at least one additional controller medication.

Read more